Dabrafenib

ATC L01EC02 · 11 markets · 35 records

Dabrafenib 11 markets · 35 records Forms

Filters

MarketUS 4 GB 4 CN 4 HK 4 CA 3 AU 3 SG 3 ES 3 FR 3 TW 2 EU 2

Strength

US 4 records · 3 shown of 3 Source openFDA NDC Directory · Data as of 2026-10-23

75 mgcapsuleTafinlar also in GB·CN·CA
+4Other 4 markets
AU SG ES TW
50 mgcapsuleTafinlar also in GB·CN·CA
+4Other 4 markets
AU SG ES TW
10 mgtabletTafinlar+1Manufacturer: Novartis Pharma Stein AG also in GB·CA·AU
+3Other 3 markets
SG ES FR

GB 4 records · 3 shown of 3 Source NHSBSA dm+d · Data as of 2026-10-19

75 mgcapsuleTafinlar also in US·CN·CA
+4Other 4 markets
AU SG ES TW
50 mgcapsuleTafinlar also in US·CN·CA
+4Other 4 markets
AU SG ES TW
10 mgtabletFinlee 10mg dispersible tablets also in US·CA·AU
+3Other 3 markets
SG ES FR

CN 4 records · 2 shown of 2 Source 国家医保局医保药品分类与代码数据库 · Data as of 2025-04-04

75 mgcapsule泰菲乐甲磺酸达拉非尼 also in US·GB·CA
+4Other 4 markets
AU SG ES TW
50 mgcapsule泰菲乐甲磺酸达拉非尼 also in US·GB·CA
+4Other 4 markets
AU SG ES TW

HK 4 records · 0 shown of 0 Source 衞生署藥物辦公室（香港）註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

4 records · 0 manufacturers 4 registros · 0 fabricantes 4 个记录 · 0 个厂家 4 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名Tafinlar ×32

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

CA 3 records · 3 shown of 3 Source Health Canada Drug Product Databas · Data as of 2026-10-23

75 mgcapsuleTafinlar also in US·GB·CN
+4Other 4 markets
AU SG ES TW
50 mgcapsuleTafinlar also in US·GB·CN
+4Other 4 markets
AU SG ES TW
10 mgtabletTafinlar also in US·GB·AU
+3Other 3 markets
SG ES FR

AU 3 records · 3 shown of 3 Source PBS Schedule API v3 (Department of · Data as of 2026-10-01

75 mgcapsuleTafinlar also in US·GB·CN
+4Other 4 markets
CA SG ES TW
50 mgcapsuleTafinlar also in US·GB·CN
+4Other 4 markets
CA SG ES TW
10 mgtabletTafinlar also in US·GB·CA
+3Other 3 markets
SG ES FR

SG 3 records · 3 shown of 3 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

75 mgcapsuleTAFINLAR HARD CAPSULE 50MG also in US·GB·CN
+4Other 4 markets
CA AU ES TW
50 mgcapsuleTAFINLAR HARD CAPSULE 50MG also in US·GB·CN
+4Other 4 markets
CA AU ES TW
10 mgtabletTafinlar also in US·GB·CA
+3Other 3 markets
AU ES FR

ES 3 records · 3 shown of 3 Source CIMA (AEMPS) · Data as of live

75 mgcapsuleTafinlar also in US·GB·CN
+4Other 4 markets
CA AU SG TW
50 mgcapsuleTafinlar also in US·GB·CN
+4Other 4 markets
CA AU SG TW
10 mgtabletFINLEE DISPERSABLES also in US·GB·CA
+3Other 3 markets
AU SG FR

FR 3 records · 3 shown of 3 Source Base de données publique des médic · Data as of 2026-11-03

10 mgtabletFINLEE 10 mg, comprimé dispersible also in US·GB·CA
+3Other 3 markets
AU SG ES
88.88 mgcapsuleTAFINLAR 50 mg, gélule
59.25 mgcapsuleTAFINLAR 50 mg, gélule

TW 2 records · 2 shown of 2 Source 衛生福利部食品藥物管理署（TFDA）全部藥品許可證資料集 · Data as of 2026-10-22

75 mgcapsuleTafinlar+1泰伏樂膠囊75毫克 also in US·GB·CN
+4Other 4 markets
CA AU SG ES
50 mgcapsuleTafinlar+1泰伏樂膠囊50毫克 also in US·GB·CN
+4Other 4 markets
CA AU SG ES

EU 2 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名Finlee 10mg dispersible tablets ×2Tafinlar ×8

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

Side-by-side table

Strength / form / release	US	GB	CA	AU	SG	CN	ES	TW	HK	EU	FR
75 mg capsule	Tafinlar	Tafinlar	Tafinlar	Tafinlar	TAFINLAR HARD CAPSULE 50MG	泰菲乐甲磺酸达拉非尼	Tafinlar	Tafinlar 泰伏樂膠囊75毫克	not recorded	not recorded	not recorded
50 mg capsule	Tafinlar	Tafinlar	Tafinlar	Tafinlar	TAFINLAR HARD CAPSULE 50MG	泰菲乐甲磺酸达拉非尼	Tafinlar	Tafinlar 泰伏樂膠囊50毫克	not recorded	not recorded	not recorded
10 mg tablet	Manufacturer: Novartis Pharma Stein AG Tafinlar	Finlee 10mg dispersible tablets	Tafinlar	Tafinlar	Tafinlar	not recorded	FINLEE DISPERSABLES	not recorded	not recorded	not recorded	FINLEE 10 mg, comprimé dispersible
88.88 mg capsule	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	TAFINLAR 50 mg, gélule
59.25 mg capsule	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	TAFINLAR 50 mg, gélule
not disclosed unknown	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	Tafinlar	Finlee 10mg dispersible tablets Tafinlar	not recorded

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

3 more strength/form rows are recorded only in HK · EU · FR and are not shown in this table. Hay 3 filas de concentración/forma registradas solo en HK · EU · FR que no se muestran en esta tabla. 另有 3 个规格/剂型仅在 HK · EU · FR 有记录（未在本表显示）。另有 3 個規格/劑型僅在 HK · EU · FR 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.